EU approves fifth anti-COVID vaccine

The European Commission (EC) granted conditional marketing authorisation (CMA) for the Nuvaxovid jab on Monday after it was greenlit by the European Medicines Agency. The US-developed vaccine joins Pfizer/BioNTech, Moderna, AstraZeneca, and Johnson & Johnson on the list of EU-approved jabs.  “This is our first protein-based vaccine”, Stella Kyriakides,